Marques, D. F. P., Rose, A. M. C., Monge, S., Mart. Association between influenza vaccination and severe outcomes in adults aged ≥ 65 years hospitalized with laboratory-confirmed influenza: a retrospective cohort study, I-MOVE hospital network, Europe,. Expert Review of Vaccines, 25(1)
Introduction
Older adults face an increased risk of influenza-related intensive care unit (ICU) admission and in-hospital death (IHD). Although vaccination reduces hospitalization, its effect on these outcomes remains uncertain. We estimated the association between influenza vaccination and both outcomes among adults aged?≥65?years hospitalized with laboratory-confirmed influenza.
Research design and methods
We conducted a retrospective cohort study using European I-MOVE hospital network data (2015/16–2024/25); vaccination was defined as vaccine receipt?≥14?days before symptom onset. We estimated pooled-season adjusted risk ratios (aRR) using Poisson regression adjusting for potential confounders. We calculated relative risk reduction (RRR) as (1?aRR)×100, overall and by age group (65–79, ≥80?years).
Results
After exclusions, 4,257 patients (five study sites, six seasons) were included. ICU admission occurred in 3% of vaccinated and 5% of unvaccinated patients; IHD occurred in 5% of both groups. RRR was 11% (95% CI: ?21–34) against ICU admission (65–79?years: ?4%; ≥80?years: 44%). RRR against IHD was 26% (95% CI: 3–43); 17% and 29% in each respective age group.
Conclusions
Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.
Older adults face an increased risk of influenza-related intensive care unit (ICU) admission and in-hospital death (IHD). Although vaccination reduces hospitalization, its effect on these outcomes remains uncertain. We estimated the association between influenza vaccination and both outcomes among adults aged?≥65?years hospitalized with laboratory-confirmed influenza.
Research design and methods
We conducted a retrospective cohort study using European I-MOVE hospital network data (2015/16–2024/25); vaccination was defined as vaccine receipt?≥14?days before symptom onset. We estimated pooled-season adjusted risk ratios (aRR) using Poisson regression adjusting for potential confounders. We calculated relative risk reduction (RRR) as (1?aRR)×100, overall and by age group (65–79, ≥80?years).
Results
After exclusions, 4,257 patients (five study sites, six seasons) were included. ICU admission occurred in 3% of vaccinated and 5% of unvaccinated patients; IHD occurred in 5% of both groups. RRR was 11% (95% CI: ?21–34) against ICU admission (65–79?years: ?4%; ≥80?years: 44%). RRR against IHD was 26% (95% CI: 3–43); 17% and 29% in each respective age group.
Conclusions
Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.
See Also:
Latest articles in those days:
- Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine 7 hours ago
- Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K 7 hours ago
- Environmental Adaptability of Influenza A(H9N2) Virus in the Process of Genetic Evolution 2 days ago
- Evaluating sampling strategies for the detection of avian influenza viruses in the environment 2 days ago
- HA1-T138A and HA1-Q226L substitutions in H3N2 canine influenza virus contribute to binding to human-type α2,6-linked sialic acid receptors 2 days ago
[Go Top] [Close Window]


